Issued Patents All Time
Showing 1–25 of 33 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11938101 | Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi, Christopher R. Cornell, Kieron E. Wesson | 2024-03-26 |
| 11840497 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2023-12-12 |
| 11746077 | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Andrew W. Hinman, Charles R. Holst, Angela Minnella, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2023-09-05 |
| 11667596 | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Andrew W. Hinman, Charles R. Holst, Angela Minnella, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2023-06-06 |
| 11560364 | Methods for enriching alpha-tocotrienol from mixed tocol compositions | Peter Giannousis, Noah Benjamin, Jeffrey D. BUTLER, Olivier Dapremont, James B. Falabella | 2023-01-24 |
| 11304914 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi | 2022-04-19 |
| 11186559 | Methods for enriching alpha-tocotrienol from mixed tocol compositions | Peter Giannousis, Noah Benjamin, Jeffrey D. BUTLER, Olivier Dapremont, James B. Falabella | 2021-11-30 |
| 11174212 | 2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders | Andrew W. Hinman, Charles R. Holst, Angela Minnella, Sean Pintchovski, Jeffrey K. Trimmer +1 more | 2021-11-16 |
| 10968166 | 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2021-04-06 |
| 10751302 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi | 2020-08-25 |
| 10745371 | Methods for enriching alpha-tocotrienol from mixed tocol compositions | Peter Giannousis, Noah Benjamin, Jeffrey D. BUTLER, Olivier Dapremont, James B. Falabella | 2020-08-18 |
| 10251847 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Christopher R. Cornell, Kieron E. Wesson, Peter Giannousis, Shazad Suchit, Mahmoud Mirmehrabi | 2019-04-09 |
| 10202325 | Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | — | 2019-02-12 |
| 10167251 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2019-01-01 |
| 10029971 | Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | — | 2018-07-24 |
| 9932286 | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers | Guy M. Miller, Sidney Hecht, Orion D. Jankowski, Kieron E. Wesson | 2018-04-03 |
| 9567279 | Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | — | 2017-02-14 |
| 9546132 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2017-01-17 |
| 9464016 | Catechol derivatives for treatment of oxidative stress diseases | Gloria Pfister | 2016-10-11 |
| 9278085 | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers | Guy M. Miller, Sidney Hecht, Orion D. Jankowski, Kieron E. Wesson | 2016-03-08 |
| 9169196 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2015-10-27 |
| 9162957 | Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | — | 2015-10-20 |
| 8716527 | 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases | Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, William D. Shrader, Christopher R. Cornell | 2014-05-06 |
| 8519001 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2013-08-27 |
| 7968746 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Orion D. Jankowski, Kieron E. Wesson, William D. Shrader | 2011-06-28 |